Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
Stock
EWTX
EWTX News & Events
-
Add to Watchlist
Trade EWTX Autonomously
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
EWTX News
Biotech Companies Achieve Significant Milestones
Jun 16 2026
Newsfilter
Edgewise Initiates Late-Stage Trial for EDG-7500 Treatment
Jun 16 2026
seekingalpha
Edgewise Therapeutics Reports Positive Phase 2 Results for EDG-7500 in HCM Patients
Jun 16 2026
PRnewswire
Edgewise Grants Stock Options to New Employees
Jun 03 2026
PRnewswire
Servier Acquires Edgewise's Muscular Dystrophy Operations
Jun 01 2026
stocktwits
Edgewise to Sell Muscle Disease Business for $1.55 Billion
Jun 01 2026
PRnewswire
Biotech Fund Sells Erasca Stake After 700% Rally
May 18 2026
Yahoo Finance
Achieve Life Sciences Appoints Three Senior Executives
May 12 2026
Newsfilter
Show More News
EWTX Events
06/16 10:31
Edgewise Therapeutics Shares Drop 9.9% to $31.71
Edgewise Therapeutics is down -9.9%, or -$3.50 to $31.71.
Show More Events
EWTX Monitor News
Edgewise Therapeutics Reports Positive Phase 2 Results for EDG-7500
Jun 16 2026
Edgewise Therapeutics sells muscle disease business for $1.55 billion
Jun 05 2026
Edgewise Therapeutics sells muscle disease business for $1.55 billion
Jun 01 2026
Edgewise Therapeutics' EDG-7500 Positioned Favorably Amid Cytokinetics' Trial Success
May 05 2026
EWTX Earnings Analysis
No Data
People Also Watch
